LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 37.71 | 27.76 | 3807 | 2877 | 1.3230 | 1.0854 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 39.41 | 27.76 | 109 | 3105 | 0.0351 | 0.2226 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 39.41 | 27.76 | 3737 | 3105 | 1.2033 | 1.0551 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 39.41 | 27.76 | 611 | 3105 | 0.1967 | 0.5750 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 39.41 | 27.76 | 4054 | 3105 | 1.3054 | 1.0799 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 41.11 | 27.76 | 155 | 3331 | 0.0465 | 0.2827 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 41.11 | 27.76 | 3993 | 3331 | 1.1986 | 1.0531 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 41.11 | 27.76 | 632 | 3331 | 0.1897 | 0.5722 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 41.11 | 27.76 | 4313 | 3331 | 1.2946 | 1.0762 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 42.81 | 27.76 | 196 | 3596 | 0.0545 | 0.3212 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 42.81 | 27.76 | 4337 | 3596 | 1.2060 | 1.0541 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 42.81 | 27.76 | 709 | 3596 | 0.1972 | 0.5869 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 42.81 | 27.76 | 4657 | 3596 | 1.2949 | 1.0750 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 44.52 | 27.76 | 273 | 3884 | 0.0703 | 0.3781 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 44.52 | 27.76 | 4787 | 3884 | 1.2324 | 1.0595 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 44.52 | 27.76 | 689 | 3884 | 0.1774 | 0.5692 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 44.52 | 27.76 | 5035 | 3884 | 1.2962 | 1.0741 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.22 | 27.76 | 353 | 4125 | 0.0856 | 0.4225 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.22 | 27.76 | 5202 | 4125 | 1.2611 | 1.0653 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.22 | 27.76 | 756 | 4125 | 0.1833 | 0.5809 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.22 | 27.76 | 5496 | 4125 | 1.3324 | 1.0811 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 47.93 | 27.76 | 369 | 4421 | 0.0835 | 0.4243 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 47.93 | 27.76 | 5630 | 4421 | 1.2733 | 1.0672 | MN20160318_Q01 | J13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 47.93 | 27.76 | 835 | 4421 | 0.1889 | 0.5925 | MN20160318_Q01 | M19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 47.93 | 27.76 | 5980 | 4421 | 1.3525 | 1.0843 | MN20160318_Q01 | M19 |